BackErnexa Therapeutics Warrants Overview
Ernexa Therapeutics Inc. Warrants

Ernexa Therapeutics Warrants Return on Equity

Latest ROE for Ernexa Therapeutics Warrants: -320.98% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-320.98%

Return on Equity

-320.98%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Ernexa Therapeutics Warrants (ERNAW) FAQ

As of the most recent data, ERNAW shows a ROE of -320.98%. That is below the Telecommunications sector average of 6.48%. Scroll down for historical charts and peer comparison views.

The Telecommunications sector average ROE is about 6.48%. Ernexa Therapeutics Warrants is at -320.98%, which is lower that average. That is roughly 5052.3% below the sector mean. Use the comparison chart on this page to see how ERNAW stacks up against individual peers as well.

Check the historical chart to see whether ERNAW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ernexa Therapeutics Warrants with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Ernexa Therapeutics Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -320.98%) with ownership activity and broader fundamentals.

The Telecommunications average ROE is about 6.48%, while ERNAW is at -320.98%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.